Hosted on MSN1mon
JonesResearch upgrades IN8bio to Buy on ‘impressive’ AML data
The firm views the AML data as “impressive” and upgraded the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today ...
Nasdaq1mon
IN8bio Reports Positive Phase 1 Data For INB-100 In AML Patients
The data, presented at the 2025 Transplantation & Cellular Therapy or TCT Meetings, showed that INB-100 demonstrated impressive durability, with no AML relapses observed in any patients over a ...